(Q45857890)

English

A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase

scientific article published on 28 April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

author name string

Cornetta K

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

Croop J

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

Dropcho E

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

Abonour R

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

Kreissman S

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

Reeves L

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

Erickson LC

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

Williams DA

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

publication date

28 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

13

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

886-895

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700963

0 references

Transfection with a cDNA encoding a Ser31 or Ser34 mutant human dihydrofolate reductase into Chinese hamster ovary and mouse marrow progenitor cells confers methotrexate resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Retrovirus-mediated transfer and expression of drug resistance genes in human haematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Myeloprotection with drug-resistance genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Genetic chemoprotection with mutant O6-alkylguanine-DNA-alkyltransferases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Progress in the use of gene transfer methods to treat genetic blood diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Feasibility of multidrug resistance (MDR-1) gene transfer in patients undergoing high-dose therapy and peripheral blood stem cell transplantation for lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Clinical relevance of MGMT in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Dose-intensive, time-compressed procarbazine, CCNU, vincristine (PCV) with peripheral blood stem cell support and concurrent radiation in patients with newly diagnosed high-grade gliomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Retroviral transduction of human CD34+ cells on fibronectin fragment CH-296 is inhibited by high concentrations of vector containing medium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Infection of human cells with murine amphotropic replication-competent retroviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

MGMT: its role in cancer aetiology and cancer therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

In vivo selection of human hematopoietic cells in a xenograft model using combined pharmacologic and genetic manipulations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

21 January 2018

Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of hematopoietic cells against combined O6-benzylguanine and chloroethylnitrosourea treatment by mutant forms of O6-methylguanine DNA methyltransferase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700963

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700963

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16645619

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45857890&oldid=2086742291"